Status:
UNKNOWN
Nebulized N-Acetyl Cysteine for Bronchiolitis in Inpatient Hospital Use
Lead Sponsor:
Carilion Clinic
Conditions:
Bronchiolitis Acute
Eligibility:
All Genders
1-2 years
Phase:
PHASE4
Brief Summary
Bronchiolitis is the major cause of hospital admission in infants \< 6 months of age and usually viruses like Respiratory syncytial virus (RSV), human metapneumo virus, Adeno virus, para-influenza vir...
Detailed Description
A randomized clinical trial with blinding of person assigned for assessing and scoring the patients. The participants will include children less than 2 yrs. age admitted to the Pediatric Intensive Car...
Eligibility Criteria
Inclusion
- Full term new born neonates up to patients \< 2yrs
- Respiratory score ≥2
- Otherwise healthy with new respiratory illness
Exclusion
- Prematurity \<34 weeks for patients \<6 months age.
- h/o congenital heart disease requiring baseline medication
- Patient received diagnosis of Asthma or reactive airway disease in past.
- Anatomic airway defect.
- Immunodeficiency
- Chronic lung disease
- Patients who have had previous bronchiolitis \< 4 weeks ago
- Patients intubated for acute bronchiolitis during the current admission.
- h/o Larynogomlacia, bronchomalacia or tracheomalacia.
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2020
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT03364218
Start Date
February 1 2018
End Date
May 31 2020
Last Update
September 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carilion Clinic
Roanoke, Virginia, United States, 24014